"We certainly have to be careful," he said. "Some of these drugs clearly have the potential for misuse and addiction. But there may be aspects that perhaps have a potential benefit, particularly if we could find a way to isolate their helpfulmechanisms of action." For example, this might ...
Nevertheless, for the moment, subjective response remains the regulatory standard against which psychotropic drugs will be measured. DOES THE PSILOCYBIN EXPERIENCE REALLY BELONG IN MEDICINE? The unspoken assumption, which I think we both share, is that the use of psilocybin at this stage requires a...
An editorial is presented on the growing interest in using psychedelic drugs for treating various mental health disorders and emphasizes the importance of the therapeutic context and psychotherapy in conjunction with these compounds. It mentions the potential benefits of psychedelic t...
one of the pre-eminent global research centres in psychedelics. “They have been closely involved in designing the trial protocols for the integration of the drugs and therapy,” said Rands. The company has now initiated
In addition to increasing activity in regions of the brain involved in emotion regulation and cognitive flexibility, psychedelic drugs have been demonstrated to decrease amygdala activation. This alteration in brain activity may help to weaken the connections between traumatic memories and fear responses,...
An increasing number of clinicians and researchers have become interested in the potential of psychedelic drugs for the treatment of mental health disorders, including depression, anxiety, posttraumatic stress disorder, eating disorders, and addictions.1,2 Currently, most psychedelic compounds are illegal ...
Renaissance of psychedelic therapy Research into psychedelic therapies started in the West in the 1940s, after the discovery of lysergic acid diethylamide (LSD). However, research ground to a halt in the 1960s, after people started to view psychedelics as drugs of abuse and associate them with ...
Clinical trials repeatedly show promise for exploring psychedelics, yet a lingering war on drugs or fear of risks specific to psychedelics continues to introduce obstacles to funding, research, and treatment. I did not attend the Breaking Convention conference, though I have attended similar meetings ...
Who is it suitable for? What are the implications of using these substances, which are classified as illegal drugs? And for Israelis, what are the chances of this treatment being approved here as well? Dr. Ofir Livne What are MDMA and psilocybin?These two psychedelic substances are known as...
psychologists’ attitudes toward the emerging use of psychedelics like psilocybin and MDMA in psychotherapy. The study, published in the Journal of Psychoactive Drugs, found psychologists hold cautiously optimistic views about the promise of psychedelic-assisted therapy but also harbor concerns about safety...